D.J. Martin

Bone Health Technologies | Osteoboost is focused on bringing effective, safe therapies for improving bone health to the millions of people looking for alternatives or additions to their current treatment options.

Harvest Thermal provides affordable and low carbon heating, hot water and cooling systems that reduce our impact on the planet while providing superior comfort, healthier and safer homes. The Harvest Thermal Pod is a cloud connected IoT device that is machine learning enabled. The Harvest Thermal is the most efficient electrified hot water and heating system on the market.

OCON Therapeutics develops innovative and safe intra-uterine medical solutions that are inspired by women’s bodies and anatomy, to better the lives of women everywhere. In the past decade we have developed the IUB™ platform, our proprietary intrauterine ball-shaped technology, utilising super-elastic alloy Nitinol to carry long lasting hormone-free contraception and other drugs. OCON’s first product, the IUB™ Ballerine®, is a CE approved copper-based hormone-free intrauterine contraceptive, effective for up to 5 years, and already in use by over 100,000 women in 24 countries, including EU member countries, South Africa and Israel. The Company is currently enlisting patients for its phase II clinical trials with the IUB™ SEAD, a disposable, point of care therapy for the treatment of abnormal uterine bleeding (AUB), affecting 25% of women in the reproductive age. The SEAD (Spherical Endometrial Ablation Device) is designed to be a pain-free, non-invasive and cost-effective alternative for aggressive, invasive, painful and costly ablation procedures hundreds of thousands of women currently endure. In addition, we are working on a strong pipeline of more IUB™ based drug products, using the frame for myomas and other uterine indications. OCON’s technology platform and products are protected by a broad portfolio of patents and trademarks.

Repurpose was founded in 2010 with a mission to reduce single-use plastics in our environment. We are a team of eco-entrepreneurs with a passion for spreading awareness of the perils of plastic and offering consumers solutions with our products, which are available at 17,000+ stores across the nation. Ranked more than once as one of Inc 500’s fastest growing private companies, Repurpose is a dynamic brand that is turning the tableware category on its head. Were passionate individuals working in a fast-paced environment offering competitive health benefits, unlimited PTO, and quarterly team wellness events. Headquartered in sunny DTLA, our company is growing quickly and we’ll give you the opportunity to do the same.

Aluna is designed to help you understand your chronic respiratory condition (such as asthma) and allow you to take control of your lung health. Using a combination of machine learning, our spirometer device and mobile app, you can now use the daily measurements to help you understand and manage your asthma.

CNote is an AI-powered cash management platform unlocking the trillion dollar community finance sector to help corporations, foundations and individuals achieve better returns and liquidity while driving positive community development. Corporate leaders including Apple, Mastercard, Patagonia, PayPal and Netflix use CNote’s platform to advance their diversity, equity and inclusion goals by authentically supporting low-income communities and communities of color. They earn returns comparable to what conventional products yield—while providing essential capital to minority depository institutions (MDIs), community development financial institutions (CDFIs), low-income designated (LID) credit unions and other impact finance organizations. Individuals can also invest through the platform to support an economy that works for everyone. CNote founders Catherine Berman, CEO, and Yuliya Tarasava, COO, launched CNote in 2016 with a mission to close the wealth gap through financial innovation. Based in Oakland, California, CNote is a Certified B Corporation and is GIIRS rated.

BRAINBox Solutions™ multi-modality approach is led by the leaders in the industry. It will include blood biomarker panels available on a point of care instrument and standard laboratory systems, as well as neurocognitive testing, to provide objective evidence of injury and prediction of patient recovery.

Abilitech Medical, Inc. is a medical device company based in Eden Prairie, Minnesota. Every day we strive to create and build innovative solutions that restore function and independence to those affected by neuromuscular conditions such as multiple sclerosis, spinal muscular atrophy, spinal cord injury, Duchenne muscular dystrophy, amyotrophic lateral sclerosis and brachial plexus injury. These conditions rob patients of their physical strength, independence and ability to actively engage with their friends and family. Ultimately, our goal is to empower those who live with neuromuscular arm weakness by restoring their independence and improving their quality of life. This product is commercially available.

Candesant Bio is a clinical stage company that is driving research and development of its novel, investigational sweat control patch designed to offer underarm sweat relief with no downtime. Learn more about our company and technology by visiting Candesant.com

Kuli Kuli was founded by a female Peace Corps Volunteer on a mission to empower women and fight climate change. We sustainably source the purest, most nutritious leaves of the moringa tree to produce superfood products that improve the lives of women around the world. Nourishing you, nourishing the world.

Avails Medical, Inc. is a pioneer in rapid, automated solutions for antibiotic susceptibility testing (AST). Founded by a team of Stanford postdoctoral researchers, Avails’ electronic biosensor technology is designed to improve affordability and speed in pathogen quantification and susceptibility testing directly from human specimens for clinical laboratories by eliminating manual, time-consuming culturing steps. Avails’ eQUANT(TM) platform enables microbiology labs to generate an automated 0.5 McFarland equivalent (eMcF) directly from positive blood cultures (PBC), removing as many as 18+ hours from the standard workflow by eliminating the need for subcultures. The eQUANT system is FDA 510(k) cleared. IN DEVELOPMENT: Avails is also developing a rapid phenotypic AST platform being designed for use directly from PBCs as well as cultured isolates. Avails electrical biosensor platform fits within the laboratorys existing workflow and budget, serving clinical labs in smaller community hospitals to larger academic centers and centralized laboratories.

Alydia Health has been recently acquired as a US subsidiary of Organon

Madorra is empowering women to live fuller, richer, healthier lives. Our first product is changing the paradigm for treating vaginal dryness by providing a medical device solution to a problem that has previously only been served by pharmaceuticals. We’re giving postmenopausal women and breast cancer survivors the power to choose the non-hormonal treatment option they want. Madorra has developed the first, non-invasive, non-hormonal medical device to treat vaginal atrophy. This is an easy-to-use, at-home device, providing both immediate and long-term benefits.

Mi Padrino was a marketplace that makes planning Hispanic celebrations easy and effective. https://youtu.be/cWOHq984o6c Mi Padrino was successfully acquired in 2022

PrecisionLife is a clinical-stage precision medicine company creating better diagnostic tools and more personalized treatment options to predict, treat, and prevent complex chronic diseases. Our AI-led platform is unparalleled in its understanding of disease biology. Identifying underlying causes of disease and biomarkers to stratify patients by molecular mechanism. Our unique insights and mechanstic® tests accurately link individuals to the drug targets, clinical trials and treatments that will benefit them - increasing the probability of success in drug development and leading to earlier, more accurate and effective disease prediction, diagnosis, treatment, and prevention. Reducing the global burden of chronic disease and improving health for billions of people.

Formed in 2010, Terviva is a food and agriculture company that delivers tasty and nourishing plant-based food ingredients from the pongamia tree. We provide patented high-yielding trees and offer proprietary bean processing to create the worlds most sustainable oil and protein food ingredients. Pongamia trees restore farmland to productive use, helping farmers feed people while taking care of the planet. Learn more at www.Terviva.com.

Materna Medical is a novel OBGYN platform company defining a $6B market with core technologies addressing unmet needs in womens pelvic health. With headquarters in Mountain View, California, Materna pulls from the top minds in MedTech to truly transform the standard of care in OBGYN. With a diverse team of engineers, scientists, researchers, and commercial leaders, Materna Medical’s mission is to empower women to protect their pelvic health.

Bone Health Technologies | Osteoboost is focused on bringing effective, safe therapies for improving bone health to the millions of people looking for alternatives or additions to their current treatment options.

Harvest Thermal provides affordable and low carbon heating, hot water and cooling systems that reduce our impact on the planet while providing superior comfort, healthier and safer homes. The Harvest Thermal Pod is a cloud connected IoT device that is machine learning enabled. The Harvest Thermal is the most efficient electrified hot water and heating system on the market.

OCON Therapeutics develops innovative and safe intra-uterine medical solutions that are inspired by women’s bodies and anatomy, to better the lives of women everywhere. In the past decade we have developed the IUB™ platform, our proprietary intrauterine ball-shaped technology, utilising super-elastic alloy Nitinol to carry long lasting hormone-free contraception and other drugs. OCON’s first product, the IUB™ Ballerine®, is a CE approved copper-based hormone-free intrauterine contraceptive, effective for up to 5 years, and already in use by over 100,000 women in 24 countries, including EU member countries, South Africa and Israel. The Company is currently enlisting patients for its phase II clinical trials with the IUB™ SEAD, a disposable, point of care therapy for the treatment of abnormal uterine bleeding (AUB), affecting 25% of women in the reproductive age. The SEAD (Spherical Endometrial Ablation Device) is designed to be a pain-free, non-invasive and cost-effective alternative for aggressive, invasive, painful and costly ablation procedures hundreds of thousands of women currently endure. In addition, we are working on a strong pipeline of more IUB™ based drug products, using the frame for myomas and other uterine indications. OCON’s technology platform and products are protected by a broad portfolio of patents and trademarks.